GENOR-B: Next Day Disclosure Return
GENOR-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2024
GENOR-B: Notification Letter and Request Form to Non-registered Holders
GENOR-B: Notification Letter and Change Request Form to Registered Holders
GENOR-B: FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD AT ROOM 401-17, 4F, BUILDING 6, 690 BIBO ROAD, PUDONG NEW DISTRICT, SHANGHAI, CHINA ON THURSDAY, 27 JUNE 2024 AT 10:00 A.M.
GENOR-B: (1) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (2) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES; (3) PROPOSED RE-APPOINTMENT OF AUDITOR; (4) PROPOSED ADOPTION OF EIGHTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSO
GENOR-B: NOTICE OF ANNUAL GENERAL MEETING
GENOR-B: 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
GENOR-B: 2023 ANNUAL REPORT
GENOR-B: Next Day Disclosure Return
GENOR-B: Next Day Disclosure Return
GENOR-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2024
GENOR-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023 AND PROPOSED ADOPTION OF THE EIGHTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
GENOR-B: VOLUNTARY ANNOUNCEMENT - NATIONAL MEDICAL PRODUCTS ADMINISTRATION ACCEPTS NEW DRUG APPLICATION FOR GB491 (LEROCICLIB)
GENOR-B: DATE OF BOARD MEETING
GENOR-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 29 February 2024
GENOR-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2024
GENOR-B: Next Day Disclosure Return
GENOR-B: Next Day Disclosure Return
GENOR-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2023
No Data